Skip to main content

Effects of Gabexate Mesilate (FOY) on Amylase and Phospholipase A2 in Human Serum and Pancreatic Juice

Digestive Diseases and Sciences volume 50, pages 868–873 (2005)Cite this article

Abstract

The precise inhibitory action of gabexate mesilate (GM) on the various pancreatic enzymes remains unclear. We designed this study to investigate the enzyme inhibitory action of GM in the serum and directly in the pancreatic juice. We observed 16 cases with postoperative pancreatic drainage. Patients were randomly assigned to one of two groups, to receive GM at a dose of 600 mg/24 hr (treated group: 8 patients) or a physiological solution (control group: 8 patients) by continuous intravenous infusion. In both groups pancreatic juice and serum were sampled three times: before infusion began (T0) and at 12 hr (T1) and 24 hr after infusion ended (T2). At the end of the study, seven patients received octreotide and the volume of pancreatic secretion was determined. No statistical difference was observed in serum amylase and phospholipase A2 activity in the treated and control groups. On the contrary, amylase and phospholipase A2 activity in the pancreatic juice diminished significantly only in the treated group, and in these patients a GM metabolite was also detectable in the pancreatic secretion. The volume of pancreatic secretion decreased only after infusion of octreotide. The enzyme inhibition in the pancreatic gland itself and the central role of inhibition of phospholipase A2 in the enzyme cascade responsible for activating other proteases, confirm the therapeutic use of GM in acute pancreatitis. An association of GM and octreotide during acute pancreatitis should be useful because of their different mechanisms.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Kitagawa M, Naruse S, Ishiguro H, Hayakawa T: Pharmaceutical development for treating pancreatic diseases. Pancreas 16:427–431, 1998

    CAS  PubMed  Article  Google Scholar 

  2. Bassi C, Falconi M, Caldiron E, Salvia R, Sartori N, Butturini G, Contro C, Marcucci S, Casetti L, Pederzoli P: Assessment and treatment of severe pancreatitis. Protease inhibitor. Digestion 60 (Suppl 1):5–8, 1999

    Article  PubMed  Google Scholar 

  3. Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I: Diagnosis, objective assessment of severity and management of acute pancreatitis. Int J Pancreatol 25:195–210, 1999

    CAS  PubMed  Google Scholar 

  4. Trapnell JE, Rigby CC, Talbot CH, Duncan EH: A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg 61(3):177–182, 1974

    CAS  PubMed  Article  Google Scholar 

  5. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O’Neill J, Blumgart LH: A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 65:337–341, 1978

    CAS  PubMed  Article  Google Scholar 

  6. Harada H, Miyake H, Ochi K, Tanaka J, Kimura I: Clinical trial with a protease inhibitor Gabexate Mesilate in acute pancreatitis. Int J Pancreatol 9:75–79, 1991

    CAS  PubMed  Google Scholar 

  7. Valderrama R, Pèrez-Mateo M, Navarro S, Vázquez N, Sanjosé L, Adrián MJ, Estruch J: Multicenter double-blind trial of gabexate-mesilate (FOY) in unselected patients with acute pancreatitis. Digestion 51:65–70, 1992

    CAS  PubMed  Article  Google Scholar 

  8. Buchler M, Malfertheiner P, Uhl W, Scholmerich J, Stockmann F, Adler G, Gaus W, Rolle K, Beger HG: Gabexate mesilate in human acute pancreatitis. Gastroenterology 104:1165–1170; 1993

    CAS  PubMed  Google Scholar 

  9. Messori A, Rampazzo R, Scroccaro G, Olivato R, Bassi C, Falconi M, Pederzoli P, Martini N: Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis. Dig Dis Sci 40(4):734–738, 1995

    CAS  PubMed  Article  Google Scholar 

  10. Pederzoli P, Cavallini G, Falconi M, Bassi C: Gabexate mesilate vs aprotinin in human acute pancreatitis. Int J Pancreatol 2:117–124, 1993

    Article  Google Scholar 

  11. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V: Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 335:919–923, 1996

    Article  CAS  PubMed  Google Scholar 

  12. Andriulli A, Leandro G, Clemente R, Festa V, Caruso N, Annese V, Lezzi C, Lichino E, Bruno F, Perri F: Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther 12:237–245, 1998

    Article  CAS  PubMed  Google Scholar 

  13. Tanaka N, Tsuchiya, Ishii K: Comparative clinical study of FOY and Trasylol in acute pancreatitis. Adv Exp Med Biol 120B:367–368, 1979

    CAS  PubMed  Google Scholar 

  14. Okegawa T, Fujita T, Yamamoto Y, Nakai H, Miyamoto K, Matsumoto K, Tani S: Effects of FOY on experimental acute pancreatitis. Curr Med 6:1–10, 1974

    Google Scholar 

  15. Caronna R, Diana L, Di Giavannandrea R, Campedelli P, Catinelli S, Nofroni I, Sibio S, Chirletti P: Gabexate mesilate (FOY) inhibition of amylase and phospholipase A2 activity in sow pancreatic juice. J Invest Surg 16:345–351, 2003

    PubMed  Article  Google Scholar 

  16. Hoffman GE, Schmidt D, Bastian B, Guder WG: Photometric determination of phospholipase A. J Clin Biochem 24 (11):871–875, 1986

    Google Scholar 

  17. Di Giovannandrea R, Diana L, Fiori M, Ferretti E, Foglietta G, Caronna R, Severini G: Determination of ethyl-p-hydroxybenzoate in sow pancreatic juice by reversed-phase high-performance liquid chromatography. J Chromatogr B 751:365–369, 2001

    CAS  Article  Google Scholar 

  18. Keim K, Goke B: Pancreatic secretion in the rat influenced by the low molecular weight serine proteinase inhibitor gabexate mesilate. Eur J Clin Invest 16:519–525, 1986

    CAS  PubMed  Article  Google Scholar 

  19. Freise J, Melzer P, Schmidt FW, Horbach L: Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients. Z Gastroenterol 24(4):200–211, 1986

    CAS  PubMed  Google Scholar 

  20. Freise J, Schmidt FW, Magerstedt P, Schmid K: Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis. Clin Biochem 18(4):224–229, 1985

    CAS  PubMed  Article  Google Scholar 

  21. Gronroos JM, Nevalainen TJ: Phospholipase A2 in acute pancreatitis: clinical value of phospholipase A2 measurements. Prog Surg 24:182–186, 1997

    CAS  Article  Google Scholar 

  22. Arbibe L, Vial D, Touqui L: Phospholipase A2 and acute respiratory distress syndrome. Prog Surg 24:79–87, 1997

    CAS  Article  Google Scholar 

  23. Uhl W, Buchler MW: Phospholipase A2 in surgical intensive care patients. Prog Surg 24:187–199, 1997

    Article  Google Scholar 

  24. Royston D: Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass. J Cardiovasc Pharmacol 27 (Suppl 1):S42–S49, 1996

    CAS  PubMed  Article  Google Scholar 

  25. Watanabe S: Acute pancreatitis:overview of medical aspects. Pancreas 16(3):307–311, 1998

    CAS  PubMed  Article  Google Scholar 

  26. Tamura Y, Hirado M, Okamura K, Minato Y, Fujii S: Synthetic inhibitors of trypsin, kallicrein, thrombin, C1r and C1esterase. Biochim Biophys Acta 484:417–422, 1977

    CAS  PubMed  Google Scholar 

  27. Baxter JN, Jenkins SA, Day DW, Roberts NB, Cowell DC, Mackie CR, Shields R: Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg 72:382–385, 1985

    CAS  PubMed  Article  Google Scholar 

  28. McKay CJ, Imrie CW, Baxter JN: Somatostatin and somatostatin analogues—Are they indicated in the management of acute pancreatitis? Gut 34:1622–1626, 1993

    CAS  PubMed  Article  Google Scholar 

  29. Lamberts SWJ, Van Der Lely A, De Herder WW, Hofland LJ: Octreotide. N Engl J Med 334(4):246–254, 1996

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Istituto Dipartimentalizzato di Chirurgia d’Urgenza e Pronto Soccorso, Università di Roma “La Sapienza,” Viale del Policlinico 155, 00161, Roma, Italy

    Roberto Caronna MD, PhD & Piero Chirletti MD

  2. Dipartimento di Medicina Sperimentale, Università di Roma “La Sapienza,” Viale del Policlinico 155, 00161, Roma, Italy

    Italo Nofroni MD

  3. Dipartimento di Chirurgia “Pietro Valdoni,”, Università di Roma “La Sapienza,” Viale del Policlinico 155, 00161, Roma, Italy

    Simone Sibio MD & Paolo Sammartino MD, PhD

  4. Istituto Superiore di Sanità, Laboratorio di Biochimica Clinica, Viale Regina Elena 299, 00161, Roma, Italy

    Loretta Diana PhD

  5. Dipartimento Emergenza Accettazione, Azienda Policlinico Umberto I, Viale del Policlinico 155, 00161, Roma, Italy

    Stefania Catinelli MD

  6. Istituto Dipartimentalizzato di Chirurgia d’Urgenza e Pronto Soccorso, Università di Roma “La Sapienza,” Viale del Policlinico 155, 00161, Rome, Italy

    Roberto Caronna MD, PhD

Authors
  1. Roberto Caronna MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Loretta Diana PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Italo Nofroni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simone Sibio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stefania Catinelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paolo Sammartino MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Piero Chirletti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberto Caronna MD, PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Caronna, R., Diana, L., Nofroni, I. et al. Effects of Gabexate Mesilate (FOY) on Amylase and Phospholipase A2 in Human Serum and Pancreatic Juice. Dig Dis Sci 50, 868–873 (2005). https://doi.org/10.1007/s10620-005-2655-0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-005-2655-0

Key Words

  • gabexate mesilate
  • enzyme inhibition
  • pancreatic secretion